Crossmark

Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on screening and treatment of tuberculosis infection in patients with inflammatory bowel disease

Crossref DOI link: https://doi.org/10.1016/j.gastre.2020.04.006

Published Print: 2021-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Riestra, Sabino

Taxonera, Carlos

Zabana, Yamile

Carpio, Daniel

Beltrán, Belén

Mañosa, Míriam

Gutiérrez, Ana

Barreiro-de Acosta, Manuel
Funding

Funding for this research was provided by:

Takeda Canada

AbbVie

Ferring

Meso Scale Diagnostics

AbbVie

Janssen Biotech

Pfizer

Meso Scale Diagnostics

Shire

Ferring

Meso Scale Diagnostics

AbbVie

Janssen Biotech

Pfizer

Shire

Ferring

Meso Scale Diagnostics

Takeda Canada

AbbVie

Takeda Canada

AbbVie

Meso Scale Diagnostics
License Information

Text and Data Mining valid from 2021-01-01

Text and Data Mining valid from 2021-01-01

Version of Record valid from 2021-02-24
More Information

This article is maintained by: Elsevier

Article Title: Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on screening and treatment of tuberculosis infection in patients with inflammatory bowel disease

Journal Title: Gastroenterología y Hepatología (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.gastre.2020.04.006

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.gastrohep.2020.04.006

Content Type: simple-article

Copyright: © 2020 The Authors. Published by Elsevier España, S.L.U.

Document is current

Any future updates will be listed below